Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoalbuminemia as a Predictive Biomarker of Dyspnea Response to Dexamethasone and Placebo in Patients With Cancer: Secondary Analysis of the ABCD Randomized Clinical Trial.

JCO precision oncology·2026
Same author

Decision tree model to predict one-year survival in ambulatory patients with advanced cancer.

PloS one·2026
Same author

Beyond the binary: a nationwide study of physician decision orientations toward artificial hydration in terminal cancer care.

The oncologist·2026
Same author

Efficacy of a structured rehabilitation program for patients with terminal cancer: A multicenter randomized controlled trial.

Cancer·2026
Same author

Tuberculosis Infection: Diagnosis and Management.

Cold Spring Harbor perspectives in medicine·2026
Same author

Prediction of 48-h Intensive Care Unit Mortality in Hospitalized Cancer Patients: Performance of the EPIC Deterioration Index and Sequential Organ Failure Assessment Score.

Journal of intensive care medicine·2026

Related Experiment Video

Updated: Jun 9, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223

Validation of Modified Objective Prognostic Score in Patients with Advanced Cancer in Taiwan.

Yusuke Hiratsuka1,2, Sang-Yeon Suh3,4, Seok Joon Yoon5

  • 1Department of Palliative Medicine, Takeda General Hospital, Aizuwakamatsu, Japan.

Palliative Medicine Reports
|October 23, 2024
PubMed
Summary

The modified Objective Prognostic Score (mOPS-B) better predicts 2-week mortality in advanced cancer patients in Taiwan than the Karnofsky Performance Status (KPS). This validated prognostic tool aids palliative care unit admissions.

Keywords:
advanced cancerpalliative careprognosticationvalidity

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Related Experiment Videos

Last Updated: Jun 9, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

223
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Area of Science:

  • Palliative Care Medicine
  • Oncology
  • Biostatistics

Background:

  • The Objective Prognostic Score (OPS) requires validation for Taiwanese palliative care settings.
  • Modified versions of OPS (mOPS) aim to improve prognostic accuracy in advanced cancer patients.

Purpose of the Study:

  • To compare the predictive accuracy of mOPS-B and Karnofsky Performance Status (KPS) for 2-week mortality in Taiwanese advanced cancer patients.
  • To evaluate mOPS-B as a potential screening tool for palliative care unit (PCU) admissions.

Main Methods:

  • Secondary analysis of a multicenter cohort study in Taiwan.
  • Comparison of mOPS-B (without lab tests) and KPS for predicting 2-week survival.
  • Assessment of model accuracy using sensitivity, specificity, and AUROC; calibration plots and NRI were also used.

Main Results:

  • The study included 317 advanced cancer patients with a median survival of 14.0 days.
  • mOPS-B demonstrated higher sensitivity (0.82) and AUROC (0.69) than KPS (0.77 sensitivity, 0.65 AUROC) for 2-week survival prediction.
  • Net reclassification index (NRI) indicated mOPS-B (22%) offered superior 2-week survival prediction compared to KPS.

Conclusions:

  • The mOPS-B model shows greater accuracy in predicting 2-week survival for advanced cancer patients in Taiwan.
  • mOPS-B may be a more effective screening tool than KPS for PCU admissions due to its improved predictive performance.